Skip to main content
Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
1.470
+1.470 (0.00%)
Feb 28, 2025, 3:00 PM EST

Silence Therapeutics Revenue

In the year 2024, Silence Therapeutics had annual revenue of 43.26M GBP with 36.71% growth. Silence Therapeutics had revenue of 29.11M in the quarter ending December 31, 2024, with 247.94% growth.

Revenue
43.26M GBP
Revenue Growth
+36.71%
P/S Ratio
n/a
Revenue / Employee
396.86K GBP
Employees
109
Market Cap
204.01M USD

Revenue Chart

* This company reports financials in GBP.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202443.26M11.62M36.71%
Dec 31, 202331.64M9.99M46.12%
Dec 31, 202221.66M9.24M74.43%
Dec 31, 202112.42M6.94M126.59%
Dec 31, 20205.48M5.24M2,145.49%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.79B
SS Innovations International 16.04M
Veradigm 1.53B
Elite Pharmaceuticals 70.00M
Glass House Brands 188.29M
Northwest Biotherapeutics 1.60M
SANUWAVE Health 29.30M
BioStem Technologies 210.49M
Revenue Rankings

Silence Therapeutics News

More News